Oregon House Passes Bill to End Hard Drug Decriminalization
There are many factors in setting drug policy, which often center around the benefits or detriments to a society and its economy.
Seeking AlphaMar 1 06:42 ET
Mydecine Innovations Closes Partial Debt Settlement
Mydecine Innovations Group (0NF0.F) completed a partial settlement for its outstanding debts to an unnamed creditor, according to a Friday filing. The biotechnology company settled a $52,370.86 debt b
MT NewswiresFeb 23 05:32 ET
Psychedelic Stocks Gain After FDA Priority Review for MDMA Therapy
Seeking AlphaFeb 12 12:13 ET
Mydecine Innovations Group Receives Notice of Allowance From USPTO For MYCO-005 Compound
Mydecine Innovations Group, Inc., (MYCO.CSE) on Monday said it has received the issuance of a Notice of Allowance by the United States Patent and Trademark Office (USPTO) for their MYCO-005 compound.
MT NewswiresDec 18, 2023 07:23 ET
Mydecine Innovations Group Provided Q4 2023 Business Update
Mydecine Innovations Group, Inc., (MYCO.CSE) earlier Thursday provided a general update. The company has spent the past few months simplifying its business model, streamline workflow and processes, an
MT NewswiresOct 26, 2023 07:48 ET
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE:CYBN) and UK-based Small Pharma Inc. (OTC:DMTTF) held their re
BenzingaOct 16, 2023 15:57 ET
Mydecine Innovations Group Starts Trading on AQSE Growth Market
Mydecine Innovations Group (MYIG.AQ) on Oct. 10 commenced trading on the access segment of the AQSE Growth Market. The biotech and life sciences company aims to develop and commercialize treatments fo
MT NewswiresOct 16, 2023 01:48 ET
Psychedelic-Based Drugs Biotech Company Begins Trading On UK's AQSE Growth Market
Novel psychedelic-based drugs biotech Mydecine Innovations Group, Inc. (NEO:MYCO) (AQSE: MYIG) (OTC:MYCOF) (FSE: 0NFA) completed its admission to Access segment of the UK's stock market, AQSE Growth M
BenzingaOct 12, 2023 09:43 ET
Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings
06:17 AM EDT, 10/10/2023 (MT Newswires) -- Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings
MT NewswiresOct 10, 2023 06:17 ET
Mydecine Innovations Group GAAP EPS of -C$0.13
Seeking AlphaAug 15, 2023 07:15 ET
Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill's New Offer
Rose Hill, a Jamaica-based cultivator, supplier and exporter of premium psilocybin products and biomass to research partners and brands is now offering its first wellness retreat program under the nam
BenzingaAug 1, 2023 11:04 ET
Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update
Colorado-based next-generation psychedelics biotech Mydecine Innovations Group Inc. (OTC:MYCOF) announced that, in connection with its common share subscription agreement with a third-party investor d
BenzingaMay 30, 2023 20:30 ET
Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More
Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application
BenzingaMay 23, 2023 19:56 ET
Mydecine's Q1 2023 Reports Shows Decline In Assets And R&D, Increase In Net Loss And Accumulated Deficit
Psychedelics biotech Mydecine Innovations Group (OTC:MYCOF) shared its condensed interim (unaudited) financial results for three months ended March 31, 2023. First quarter numbers: Cash and cash equ
BenzingaMay 17, 2023 15:51 ET
Mydecine Innovations Group GAAP EPS of -$0.41
Seeking AlphaMay 16, 2023 16:40 ET
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued Oregon's 2020 measure legalizing psilocybin therapy within a regulated centers model is approaching actual imple
BenzingaMay 1, 2023 19:07 ET
New Set Of MDMA Analogs To Hit The Clinic: These Are The Latest Positive Findings
Psychedelics biotech Mydecine Innovations Group (OTC:MYCOF) is advancing the development of its novel compounds family of next-gen MDMA analogs. So far, Mydecine's compounds show promising pharmacokin
BenzingaApr 25, 2023 16:21 ET
Mydecine: 2022 Financials & Business Update By Next-Gen Psychedelics Producer, Smoke Cessation Trial And More
Colorado and Leiden-based biotech company Mydecine Innovations Group (OTC:MYCOF) has shared its financial results and business highlights for the period ended December 31, 2022. In ciphers: Total ass
BenzingaApr 3, 2023 17:14 ET
Mydecine Modifies Business Model, Says Improved Financial Position
Seeking AlphaApr 3, 2023 06:33 ET
Mydecine Innovations Group GAAP EPS of -$1.34
Seeking AlphaApr 3, 2023 03:52 ET
No Data
No Data